Nura Bio reels in $73m Series A

South San Francisco-based Nura Bio Inc, a biopharma company focused on developing neuroprotective drugs, has raised $73 million in Series A funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this